to short a biotech Company who close a R/M and trading 50% less cash value is not a good idea. SQUEEZE pending + R/M updates + pipeline from new Company... EDGE fast $5 $6 short term imho. extremly undervalued. huge jump ahead.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.